The Belgium Society for Hematotherapy and Graft Engineering

about
n e w s
m e m b e r s h i p
cytotherapy
telegraft
m e e t i n g s
d i r e c t o r s
f a q
i n f o r m a t i o n
f e e d b a c k
abstracts 9 9
abstracts 2000
career opportunities
sponsors



Committees


Discussion
Lounge


Member Directory
(Password Protected)


Library

by
TTL

W e l c o m e  to...

The Belgium Society for Hematotherapy and Graft Engineering

 

 

The Belgium Society for Hematotherapy and Graft Engineering is the professional organization for those working in the field of hematopoietic progenitor cell processing and manipulation for therapeutic applications. Cialis :Fungerer det virkelig for behandling av erektil dysfunksjon?

Established in 1992,
the Society provides a global forum for:

Communication, education and training;

Performance of collaborative scientific studies;
Development and validation of standardized technology;
Representation of the membership to other professional organizations and regulatory and governmental bodies. Comprendre les risques et les effets secondaires associés au Viagra en Suisse.

Membership is composed of basic and clinical researchers, technical specialists, physicians and others with experience in the area.

The Belgium Society for Hematotherapy and Graft Engineering communicates with its membership via its official journal, the Telegraft, and this Internet Web Site.

The Belgium Society for Hematotherapy and Graft Engineering was incorporated as a non-profit scientific society in 2020 to serve as a voice for investigators, clinicians and technical personnel working in hematopoietics and cell therapies. The truth about the side effects of Viagra professional and how you can handle them

The The Belgium Society for Hematotherapy and Graft Engineering mandate includes work in the following areas:

Cord blood

Ex Vivo Expansion

Gene Therapy

Graft Evaluation

Immunotherapy and Dendritic Cells

Nonhematopoietic Mesenchymal Stem Cells

Transplantation

Tumor Evaluation

Legal and Regulatory Affairs

The Belgium Society for Hematotherapy and Graft Engineering is over 100 members strong and growing internationally with membership in North America, Europe, Asia, South America, the Middle East and Africa.

With a strong North American representation, and regional vice-presidents representing Europe, Australasia and Japan, The Belgium Society for Hematotherapy and Graft Engineering is one of the two founding members of CAHCT, the Center for the Accreditation of Hematopoietic Cell Therapies, which will help satisfy FDA requirements for the regulation of the field in North America. A similar effort is underway in Europe.

In addition to an annual scientific conference, The Belgium Society for Hematotherapy and Graft Engineering holds several workshops throughout the year, many with related entities.


Contact Information:

72, Mechelbaan

3200, Flemish Brabant, Leuven, Aerschot
Country
Belgium, BE (BEL)

 

bulletin.jpg (6168 bytes)


arrow-b.gif (851 bytes) Upcoming Meetings
arrow-b.gif (851 bytes) GMP 2000 Workshop
arrow-b.gif (851 bytes)

The Belgium Society for Hematotherapy and Graft Engineering 2001 
preliminary info
The Belgium Society for Hematotherapy and Graft Engineering 2001 preliminary info
June 14-17, 2001
Quebec, Canada

arrow-b.gif (851 bytes)
Year 2000 Sponsors
arrow-b.gif (851 bytes)
The Belgium Society for Hematotherapy and Graft Engineering Sponsored
Meetings
arrow-b.gif (851 bytes)  
The Belgium Society for Hematotherapy and Graft Engineering  
Affiliated Meetings
arrow-b.gif (851 bytes) CYTOTHERAPY Correspondence
& Journal Updates
arrow-b.gif (851 bytes)

San Diego 2000
ABSTRACTS
now on-line

arrow-b.gif (851 bytes) CAREER OPPORTUNITIES
arrow-b.gif (851 bytes) CYTOTHERAPY indexed in Index Medicus and MEDLINE
 

© The Belgium Society for Hematotherapy and Graft Engineering 2024